Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Oncol Pharm Pract ; 28(4): 995-997, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35075939

ABSTRACT

INTRODUCTION: Filgrastim is a granulocyte colony-stimulating factor (GSCF) used in some chemotherapy regimen to prevent febrile neutropenia. Most common reaction of filgrastim are aches and pain including headaches, nausea and skin rash. CASE REPORT: We report the case of a patient who developed unusual, non-commonly reported adverse toxidermy to filgrastim. At first the eruption was limited to the lower members and genetics organs. Then it slowly spread across the whole body presenting as a polymorphic exanthematous-pustulosis lesions. MANAGEMENT & OUTCOME: A cutaneous biopsy was done, identifying a toxidermy modified by systemic treatment. A pharmacological study linked the role of filgrastim to these lesions. After switching from filgrastim to lénograstim, his lesions are completely gone and haven't flared up again. Thus, clearly imputing the use of filgrastim. DISCUSSION: The cutaneous reaction that has reported with use of GSCF are sweet syndrome, erythema nodosum, pyoderma nodosum and pyoderma gangrenosum. As far as we know, no acute generalized exanthematous pustulosis due to GSCF has been reported.


Subject(s)
Sarcoma, Ewing , Skin Diseases , Filgrastim/therapeutic use , Granulocyte Colony-Stimulating Factor , Humans , Lenograstim , Recombinant Proteins/adverse effects , Sarcoma, Ewing/drug therapy , Skin Diseases/chemically induced
2.
J Oncol Pharm Pract ; 26(8): 1931-1933, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32990193

ABSTRACT

COVID-19 is an exceptional public healthcare emergency that affected all countries. The corona virus pandemic has made the treatment of all cancers difficult. This international phenomenon represents an outbreak in medicine and this situation is a major issue for all patients, whether they are infected with the virus or not. Colorectal cancer is one of the most common malignant tumors of the digestive tract which needs special multidisciplinary care. Treatment modalities including chemotherapy and targeted therapies can weaken the immune system and then cause serious or lethal coronavirus infections. This document gives an idea about how we dealt to protect patients with colorectal cancer at Salah Azaiez Institute during COVID 19 pandemic.


Subject(s)
COVID-19/prevention & control , Colorectal Neoplasms/therapy , Infection Control/methods , Antineoplastic Combined Chemotherapy Protocols , Cancer Care Facilities , Humans , Immunocompromised Host , SARS-CoV-2 , Tunisia
3.
Urol Case Rep ; 31: 101156, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32322507

ABSTRACT

Prostate cancer is the second most frequent among men. Bones and lymph nodes are the most common sites of metastases in advanced prostate cancer. Oral cavity metastases are rare. We report a case of 65-year-old man with a prostate adenocarcinoma revealed by gingival metastasis. We analyze through this observation the clinical, morphological and therapeutic characteristics of this neoplasia.

4.
Tunis Med ; 98(10): 726-729, 2020 Oct.
Article in English | MEDLINE | ID: mdl-33479945

ABSTRACT

INTRODUCTION: Colorectal cancer (CRC) is at present the third most common malignancy in the world. With changes in lifestyle its incidence and mortality have increased during last decades. AIM: To explore the association between red meat, processed meat and risk of colorectal cancer. METHODS: We performed a case-control study, conducted from February to March 2019 at Salah Azaiez institute. One hundred and two subjects were enrolled. RESULTS: The case group included 52.9% males and 47.1% females. The control group enrolled 49%males and 51% females. The median age was 56 years old in the two groups. 63% of patients were stage I-III disease and 37% have a metastatic disease. The mean Body mass index was 24,76 Kg/m2 in CRC group was 27,39Kg/m2 in controls. CRC cases were more likely than controls to have a family history of CRC and a lower education level. There was a significant difference between cases and controls for socio-economic level and geographic origin. Ninety point two percent of cases and 76.5% of controls consume red meats, no significant association was observed between moderate red meat intake and colorectal cancer risk (p 0,063). However, a high total day meat consumption (> 100 g) was significantly associated with a high risk of CRC compared to low consumption ( <50 g) ( p=0.023). In contrast no significant association was observed when comparing all cooking methods of meet. 51% of cases and 23,5% of controls intake processed meats. Processed meat was positively associated with CRC (p 0,004). CONCLUSION: Our findings suggest that higher consumptions of red meat, the consumption of industrially processed meat increased the risk of CRC.


Subject(s)
Colorectal Neoplasms/epidemiology , Diet/statistics & numerical data , Feeding Behavior , Red Meat/statistics & numerical data , Aged , Case-Control Studies , Diet/adverse effects , Female , Humans , Incidence , Male , Middle Aged , Red Meat/adverse effects , Risk Factors , Tunisia
SELECTION OF CITATIONS
SEARCH DETAIL
...